Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable NSCLC

Summary

The purpose of this study is to treat participants with the combination of durvalumab (the study drug) and proton beam therapy. Proton beam therapy is a type of radiotherapy (RT) with a unique characteristic where the proton stops at a specific depth according to its energy. This may be advantageous in treating lung cancer because it allows for a sufficient tumor dose that may improve local control and survival while sparing normal organs at risk, such as the heart, lung, and spinal cord.

Timeline

Start

2019-08-30

Primary completion

2022-01-27

Completion

2022-01-27

Drugs

Indications